Estimations des analystes de Wall Street pour Lineage Cell Therapeutics, Inc. (LCTX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Ratios de valorisation
| Prix / Valeur comptable | 4.42 |
| EV / EBITDA | -6.05 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $2.3M | $1.8M | $1.4M | $1.5M | $773000 | $3.9M | $14.7M | $8.9M | $9.5M | $14.6M |
| Coût des Ventes | $358000 | $168000 | $302000 | $412000 | $385000 | $1.4M | $728000 | $671000 | $334000 | $845000 |
| Marge Brute | $1.9M | $1.6M | $1.1M | $1.1M | $388000 | $2.5M | $14.0M | $8.3M | $9.2M | $13.7M |
| R&D | $36.1M | $24.0M | $21.0M | $17.9M | $12.3M | $33.9M | $14.0M | $15.7M | $12.5M | $17.7M |
| Frais Généraux | $28.4M | $19.9M | $24.7M | $24.0M | $15.6M | $18.2M | $22.5M | $17.3M | $18.2M | $18.5M |
| Charges Opérationnelles | $60.9M | $42.3M | $42.1M | $39.9M | $26.8M | $51.7M | $36.5M | $33.0M | $30.6M | $35.5M |
| Résultat Opérationnel | -$59.0M | -$38.9M | -$41.8M | -$38.9M | -$26.4M | -$49.2M | -$22.5M | -$24.7M | -$21.5M | -$21.8M |
| EBITDA | -$54.2M | -$37.4M | -$37.7M | -$35.9M | -$24.4M | -$42.4M | -$25.1M | -$22.6M | -$18.0M | -$67.9M |
| Charges d'Intérêt | $747000 | $692000 | $10.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | $18.6M | -$23.3M | -$47.1M | -$19.2M | -$21.9M | -$43.3M | -$25.8M | -$23.3M | -$18.6M | -$68.6M |
| Impôts | 0 | 0 | -$346000 | -$7.4M | -$1.2M | 0 | $541000 | -$1.8M | 0 | -$5.1M |
| Résultat Net | $33.6M | -$20.0M | -$46.0M | -$11.7M | -$20.6M | -$43.0M | -$26.3M | -$21.5M | -$18.6M | -$63.5M |
| BPA | $0.35 | $-0.17 | $-0.36 | $-0.08 | $-0.14 | $-0.26 | $-0.15 | $-0.12 | $-0.09 | $-0.28 |
| BPA Dilué | $0.34 | $-0.17 | $-0.36 | $-0.08 | $-0.14 | $-0.26 | $-0.15 | $-0.12 | $-0.09 | $-0.28 |
| Actions en Circulation (Diluées) | $99.6M | $114.5M | $126.9M | $145.5M | $150.0M | $164.5M | $169.8M | $172.7M | $200.2M | $230.1M |
Prix
| Prix | $1.07 |
| Capitalisation | $267M |
| Bourse | AMEX |
| Pays | US |
Entreprises liées: ADCT · AUTL · BNTC · FULC · GALT · NGNE · OCGN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de LCTX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions